Session

IBD (Posters)

AZATHIOPRINE AND ANTI-TNF THERAPIES AFFECT THE GUT MICROBIOME DIFFERENTLY IN IBD PATIENTS
AZATHIOPRINE AND ANTI-TNF THERAPIES AFFECT THE GUT MICROBIOME DIFFERENTLY IN IBD PATIENTS

AGE RELATED PREVALENCE OF SEXUAL AND ERECTYLE DYSFUNCTION AND LOW QUALITY OF LIVE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
AGE RELATED PREVALENCE OF SEXUAL AND ERECTYLE DYSFUNCTION AND LOW QUALITY OF LIVE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

VALIDATION OF GROWTH STUDY IN A PROSPECTIVE INCEPTION COHORT OF PEDIATRIC CD PATIENTS
VALIDATION OF GROWTH STUDY IN A PROSPECTIVE INCEPTION COHORT OF PEDIATRIC CD PATIENTS

INTESTINAL ULTRASOUND IN MONITORING POSTOPERATIVE CROHN_S DISEASE
INTESTINAL ULTRASOUND IN MONITORING POSTOPERATIVE CROHN_S DISEASE

CLINICAL AND PHARMACOKINETIC IMPACT OF METHYLPREDNISOLONE PREMEDICATION WITHDRAWAL IN INFLAMMATORY BOWEL DISEASE PATIENTS ON MAINTENANCE THERAPY WITH INFLIXIMAB
CLINICAL AND PHARMACOKINETIC IMPACT OF METHYLPREDNISOLONE PREMEDICATION WITHDRAWAL IN INFLAMMATORY BOWEL DISEASE PATIENTS ON MAINTENANCE THERAPY WITH INFLIXIMAB

ULTRASONOGRAPHY TIGHT CONTROL AND MONITORING IN CROHN'S DISEASE DURING DIFFERENT BIOLOGICAL THERAPIES: A MULTICENTER STUDY
ULTRASONOGRAPHY TIGHT CONTROL AND MONITORING IN CROHN'S DISEASE DURING DIFFERENT BIOLOGICAL THERAPIES: A MULTICENTER STUDY

TO “D” OR NOT TO “D”: IS INACCURATE TESTING CAUSING OUR VITAMIN D SUPPLEMENTATION TO BE OFF THE MARK? - LESSONS FROM INFLAMMATORY BOWEL DISEASE
TO “D” OR NOT TO “D”: IS INACCURATE TESTING CAUSING OUR VITAMIN D SUPPLEMENTATION TO BE OFF THE MARK? - LESSONS FROM INFLAMMATORY BOWEL DISEASE

PROACTIVE INFLIXIMAB DRUG MONITORING INDUCES FECAL BIOMARKER REMISSION IN INFLAMMATORY BOWEL DISEASE
PROACTIVE INFLIXIMAB DRUG MONITORING INDUCES FECAL BIOMARKER REMISSION IN INFLAMMATORY BOWEL DISEASE

THE POTENTIAL ROLE OF PROCALCITONIN AS A NOVEL SERUM INFLAMMATORY BIOMARKER IN ULCERATIVE COLITIS (UC) AND CROHN_S DISEASE (CD)
THE POTENTIAL ROLE OF PROCALCITONIN AS A NOVEL SERUM INFLAMMATORY BIOMARKER IN ULCERATIVE COLITIS (UC) AND CROHN_S DISEASE (CD)

REGULATORS OF THE GUANYLATE CYCLASE PATHWAY ARE POTENTIAL NOVEL MARKERS OF MUCOSAL HEALING IN IBD
REGULATORS OF THE GUANYLATE CYCLASE PATHWAY ARE POTENTIAL NOVEL MARKERS OF MUCOSAL HEALING IN IBD

PROGNOSIS OF CROHN'S DISEASE PATIENTS RECEIVING ANTI-TNF THERAPY ACCORDING TO ENDOSCOPIC HEALING OR RADIOLOGIC HEALING
PROGNOSIS OF CROHN'S DISEASE PATIENTS RECEIVING ANTI-TNF THERAPY ACCORDING TO ENDOSCOPIC HEALING OR RADIOLOGIC HEALING

SYSTEMATIC REVIEW AND META-ANALYSIS: THE IMPACT OF CONCOMITANT IMMUNE-MEDIATED DISEASES ON THE DISEASE LOCALIZATION AND BEHAVIOUR IN PATIENTS WITH CROHN'S DISEASE
SYSTEMATIC REVIEW AND META-ANALYSIS: THE IMPACT OF CONCOMITANT IMMUNE-MEDIATED DISEASES ON THE DISEASE LOCALIZATION AND BEHAVIOUR IN PATIENTS WITH CROHN'S DISEASE

THE DIAGNOSTIC PERFORMANCE OF A TRAINED PHYSICIAN VS. A PEDIATRIC RADIOLOGIST IN PERFORMING AN INTESTINAL ULTRASOUND IN CHILDREN WITH IBD
THE DIAGNOSTIC PERFORMANCE OF A TRAINED PHYSICIAN VS. A PEDIATRIC RADIOLOGIST IN PERFORMING AN INTESTINAL ULTRASOUND IN CHILDREN WITH IBD

EFFICACY OF USTEKINUMAB FOR ACTIVE PERIANAL FISTULIZING CROHN'S DISEASE: A DOUBLE CENTER COHORT STUDY AND A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE CURRENT LITERATURE
EFFICACY OF USTEKINUMAB FOR ACTIVE PERIANAL FISTULIZING CROHN'S DISEASE: A DOUBLE CENTER COHORT STUDY AND A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE CURRENT LITERATURE

THE REAL-WORLD EFFICACY AND SAFETY OF VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES - A DOUBLE-CENTER DANISH EXPERIENCE
THE REAL-WORLD EFFICACY AND SAFETY OF VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES - A DOUBLE-CENTER DANISH EXPERIENCE

VEDOLIZUMAB CLINICAL DECISION SUPPORT TOOL PREDICTS EFFICACY OF VEDOLIZUMAB BUT NOT USTEKINUMAB IN REFRACTORY CROHN'S DISEASE
VEDOLIZUMAB CLINICAL DECISION SUPPORT TOOL PREDICTS EFFICACY OF VEDOLIZUMAB BUT NOT USTEKINUMAB IN REFRACTORY CROHN'S DISEASE

MEASUREMENT OF ULCERATED AND AFFECTED SURFACE OF THE COLON MAY PROVIDE MORE INSIGHT INTO RESPONSE COMPARED TO ENDOSCOPIC MAYO SCORE - A POST HOC ANALYSIS
MEASUREMENT OF ULCERATED AND AFFECTED SURFACE OF THE COLON MAY PROVIDE MORE INSIGHT INTO RESPONSE COMPARED TO ENDOSCOPIC MAYO SCORE - A POST HOC ANALYSIS

EFFICACY AND SAFETY OF RE-INDUCTION WITH INTRAVENOUS USTEKINUMAB IN PATIENTS WITH CROHN_S DISEASE AND LOSS OF RESPONSE TO THAT DRUG
EFFICACY AND SAFETY OF RE-INDUCTION WITH INTRAVENOUS USTEKINUMAB IN PATIENTS WITH CROHN_S DISEASE AND LOSS OF RESPONSE TO THAT DRUG

IBD-RELATED MALIGNANCIES OBSERVED IN 2015-2019 - 4 YEARS' RESULTS FROM THE PROSPECTIVE, NATIONWIDE HUNGARIAN REGISTRY
IBD-RELATED MALIGNANCIES OBSERVED IN 2015-2019 - 4 YEARS' RESULTS FROM THE PROSPECTIVE, NATIONWIDE HUNGARIAN REGISTRY

THE REAL-WORLD EFFICACY AND SAFETY OF VEDOLIZUMAB IN BIO-NAÏVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE - AN INTERIM ANALYSIS FROM A DANISH NATIONAL COHORT STUDY
THE REAL-WORLD EFFICACY AND SAFETY OF VEDOLIZUMAB IN BIO-NAÏVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE - AN INTERIM ANALYSIS FROM A DANISH NATIONAL COHORT STUDY

Item 161 - 180 / 558
1 2 3 4 5 6 7 8
9
10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28